We developed a new in vitro method of evaluating antifungal molecules. Fungal growth was determined by measuring glucose consumption, the only carbon source in a synthetic medium. First, the growth of 12Aspergilus fiumigatus strains was studied. Glucose consumption was an excellent indicator of fungal growth.Second, the partial inhibition of growth was calculated in terms of the 90%o or 50% inhibitory concentration for the 12 strains after treatment with itraconazole and amphotericin B. With a 3-day incubation time, the calculated 90% and 50%v inhibitory concentrations agreed with those obtained by a macromethod and with those reported in previous publications. Therefore, it is in this direction that we developed a new in vitro evaluation test in which partial inhibition was easily quantifiable for the filamentous fungi. In the presence of two antifungal agents, itraconazole and amphotericin B, growth inhibition corresponded to a decrease in glucose consumption. Fungal growth was evaluated in a synthetic medium by measuring the kinetics of glucose degradation.
MATERIALS AND METHODSStrains. Twelve strains of Aspergillus fumigatus were tested: 11 were isolated from patients and 1 was isolated from an aeromycological survey.The origins of the pathogenic strains were diverse: patients with hepatic transplants (strains 8, 11), lung transplants (strains 6 and 10), cystic fibrosis (strains 4, 5, and 7), lung aspergilloma with antecedent tuberculosis (strain 3), and colonization (strains 1 and 2) and patients receiving corticotherapy (strain 12). Strain 9 was isolated during an aeromycological survey.The strains were conserved at -70°C in a solution of glycerol and distilled water 1:9 (vol/vol). They were maintained by serial passage on a Sabouraud agar medium (Sanofi Diagnostics Pasteur, Marnes la Coquettes, France) containing chloramphenicol and gentamicin as antibacterial agents.Inoculum preparation. A suspension from 5-day precultures on a Sabouraud agar medium was calibrated with a hemacytometer at 106 spores per ml in sterile distilled water. Then, 2 ml was added to 18 ml of sterile Yeast Nitrogen Base with 2% glucose (YNBG) medium. The final inoculum was 105 spores per ml.Culture medium. Strain development was carried out in liquid YNBG medium containing Yeast Nitrogen Base (6.7 g; Difco, Detroit, Mich.), monohydrated glucose (20 g; Merck, Darmstadt, Germany), and distilled water to 1 liter. Aliquots of 18 ml were also prepared.Study of strain growth. A total of 900 ,ul of inoculated YNBG medium and 100 ,ul of sterile water were placed in sterile 1.5-ml microtubes (1.5-ml polypropylene microcentrifuge test tubes; Treff AG, Degershein, Switzerland). Incubation was performed at 25°C, and the glucose concentration in the medium was determined daily.Antifungal agents. An amphotericin B (graciously donated by Bristol-Myers Squibb, Paris, France) stock solution of 462 ug/ml was prepared by dissolving the powdered drug in a mixture containing dimethyl sulfoxide (Merck)-5% Tween 80 (Sigma, St. Louis, Mo.) in distilled wa...